Pharmafocus Home
    
Keyword Search
Go News Archive Features Events Appointments Jobs Contact Us About Us
Latest Features ( October )
A postcard from ... Slovakia
We take a look at how this young country is managing healthcare and controlling costs(more)
The Pharmafocus Interview: Jan Lundberg
AstraZeneca's global head of drug discovery talks about new compounds, learning from mistakes and the real heroes behind life-saving drugs.(more)
Emerging confidence
Evidence-based medicine is an evolving practice, even in the developed world, but proving value is getting tougher in emerging markets too, says Ben Shankland(more)
PharmafocusNews Register for New Alert
News for August 2007
Previous Months: September 2008 |  August 2008 |  July 2008 |  June 2008 |  May 2008 |  April 2008 |  March 2008 |  February 2008 |  January 2008 |  December 2007 |  November 2007 |  October 2007 |  September 2007 |  August 2007 |  July 2007 |  June 2007 |  May 2007 |  April 2007 |  March 2007 |  February 2007 |  January 2007 |  December 2006 |  November 2006 |  October 2006 |  September 2006 |  August 2006 |  July 2006 |  June 2006 |  May 2006 |  April 2006 |  March 2006 |  February 2006 |  January 2006 |  December 2005 |  November 2005 |  October 2005 |  September 2005 |  August 2005 |  July 2005 |  June 2005 |  May 2005 |  April 2005 |  March 2005 |  February 2005 |  January 2005 |  December 2004 |  November 2004 |  October 2004 |  September 2004 |  August 2004 |  July 2004 |  June 2004 |  May 2004 |  April 2004 |  March 2004 |  February 2004 |  January 2004 |  December 2003 |  November 2003 |  October 2003 |  September 2003 |  August 2003 |  July 2003 |  June 2003 |  May 2003 |  April 2003 |  March 2003 |  February 2003 |  January 2003 |  December 2002 |  November 2002 | 

  What is RSS?

Latest news from Datamonitor
Product roundup in cancer, HIV and arthritis..(more)

 Avastin approved as first-line treatment for lung cancer
Fast-track NICE guidance process follows European decision ..(more)

 Pfizer appoints new finance chief
Kindler looks outside pharma for new management blood..(more)

 Tysabri wins NICE approval
Now SMC will review its initial decision to reject..(more)

 Patient information high on MHRA agenda
Regulator seeks consultation with pharma, patients and doctors for its five-year plan..(more)

 Media buyers Bartlett Davis join ABPI
Membership underlines demands ABPI code makes on marketers..(more)

 Roche unveils Pegasys compliance service
twentyfour7 programme offers support to hepatitis C patients..(more)

 Improve services or lose out to private sector, government warns GPs
Surgeries under pressure to offer evening and weekend opening..(more)

 Amgen to cut jobs on the back of sales slide
Staff reduction by 14% planned after flagship products suffer major drops..(more)

 News roundup from Datamonitor
Latest product and company roundup..(more)

 Two companies to supply UK with pandemic flu vaccines
GSK and Baxter win contracts worth £155.4m..(more)

 US direct-to-consumer advertising attacked
Drug promotion on increase despite industry limitation pledge ..(more)

 Is it R.I.P. for the PPRS?
Government intent on taking UK pricing back to the drawing board..(more)

 Is London's revamp a taste of things to come for the NHS?
Darzi's controversial healthcare review would see the setting up of 'polyclinics' to fill gap between primary and hospital care ..(more)

 Conflict over plans to improve out-of-hours services
BMA condemns governement decision to use non-medical staff to plug the gaps ..(more)

 News from Datamonitor
Latest company and product roundup..(more)

 NICE claims victory in Alzheimer's court case
But High Court requests further clarification on guidance to avoid patient discrimination..(more)

 NICE to re-think blindness drugs decision
Unprecedented patient outcry could salvage Lucentis and Macugen..(more)

 Bayer buoyed by Schering integration
Acquisition enables second quarter pharma sales to more than double..(more)

 Indian court dismisses Novartis patent claim
Drug access campaigners claim victory but Novartis warns of long-term consequences ..(more)

 FDA approves Pfizer's first-in-class HIV drug
Trial results show promise for drug resistant patients..(more)

 First national dementia strategy planned
Government plans initiativess to improve awareness, diagnosis and treatment..(more)

 FDA allows Avandia to stay but damage already done
Datamonitor reports on GSK's blighted diabetes drug..(more)

 News roundup from Datamonitor
Latest drug and company developments..(more)

 ReNeuron acquires Californian base and new diabetes technology
Move opens door for ReNeuron to US biotech and stem cell therapy markets..(more)

 Tough talking ahead as government signals end to UK medicines pricing deal
Proposals to scrap PPRS and introduce value-based system..(more)

 Germany loses out in Astellas restructuring
Japanese company is latest to disinvest in hostile German environment..(more)

 Animal rights attacks fall to new low
New powers for police take effect but ABPI warns against complacency..(more)

 AstraZeneca to make further job cuts
Second round of redundancies in effort to save company $900m..(more)

 Latest news from Datamonitor
Product roundup in MS, cancer, epilepsy, HIV and obesity..(more)

 Continuous dose contraceptive launched in US
Lybrel offers women freedom from monthly bleeding..(more)

 Prevenar success boosts UK manufacturing
Investment worth £3.25m puts Wyeth's Havant site firmly on the pharma map..(more)

Are you a Pharmafocus subscriber?

Subscribe Now 

Visit our sister sites: 

InPharm.com 

Pharmafile.com 

Pharmafocus.com © 2006 Pharmafile Ltd.